Last reviewed · How we verify
Dinoprostone vaginal gel
At a glance
| Generic name | Dinoprostone vaginal gel |
|---|---|
| Also known as | cervical priming with prostaglandin gel, Prepidil, Pharmacia, Milan, Italy |
| Sponsor | University Hospital Center of Martinique |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Early V/S Delayed Induction of Labour in Patients With Prelabour Rupture of Membranes (NA)
- Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening (PHASE3)
- Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter (PHASE4)
- Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess (PHASE3)
- Comparison Between Propess and Cook Double-balloon Catheter for Cervical Priming (PHASE4)
- Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor (PHASE2)
- Efficacy and Safety of Oral Misoprostol 25 μg vs. Vaginal Dinoprostone in Induction of Labor at Term
- Induction of Labor in Term Pregnancies With Unfavourable Cervix (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dinoprostone vaginal gel CI brief — competitive landscape report
- Dinoprostone vaginal gel updates RSS · CI watch RSS
- University Hospital Center of Martinique portfolio CI